Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up

Although fluoroquinolones are first-line agents for the treatment of National Institutes of Health (NIH) category II chronic bacterial prostatitis (CBP), therapy with these agents is not always feasible due to the increasing worldwide resistance of causative uropathogens. New therapeutic options are...

Descripción completa

Detalles Bibliográficos
Autores principales: Magri, Vittorio, Montanari, Emanuele, Marras, Emanuela, Perletti, Gianpaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038489/
https://www.ncbi.nlm.nih.gov/pubmed/27698761
http://dx.doi.org/10.3892/etm.2016.3631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038489/
https://www.ncbi.nlm.nih.gov/pubmed/27698761
http://dx.doi.org/10.3892/etm.2016.3631

Ejemplares similares